Dong Chune Christopher Chung Sells 3,500 Shares of Natus Medical Inc (BABY) Stock

Natus Medical Inc (NASDAQ:BABY) VP Dong Chune Christopher Chung sold 3,500 shares of the stock in a transaction on Tuesday, May 21st. The shares were sold at an average price of $26.33, for a total transaction of $92,155.00. Following the completion of the transaction, the vice president now owns 154,398 shares of the company’s stock, valued at approximately $4,065,299.34. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Dong Chune Christopher Chung also recently made the following trade(s):

  • On Friday, May 17th, Dong Chune Christopher Chung sold 3,000 shares of Natus Medical stock. The shares were sold at an average price of $26.28, for a total transaction of $78,840.00.

Shares of BABY stock opened at $26.81 on Thursday. Natus Medical Inc has a 52-week low of $23.58 and a 52-week high of $37.95. The firm has a market capitalization of $906.93 million, a PE ratio of 18.88 and a beta of 0.54. The company has a quick ratio of 1.18, a current ratio of 1.70 and a debt-to-equity ratio of 0.18.

Natus Medical (NASDAQ:BABY) last announced its earnings results on Thursday, April 25th. The medical equipment provider reported $0.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.06 by $0.03. The business had revenue of $114.80 million during the quarter, compared to analysts’ expectations of $113.30 million. Natus Medical had a negative net margin of 8.62% and a positive return on equity of 10.75%. The firm’s revenue for the quarter was down 10.7% on a year-over-year basis. During the same quarter last year, the company posted $0.24 EPS. As a group, equities research analysts forecast that Natus Medical Inc will post 1.27 earnings per share for the current year.

BABY has been the subject of a number of recent research reports. BidaskClub upgraded shares of Natus Medical from a “hold” rating to a “buy” rating in a research note on Monday. TheStreet cut shares of Natus Medical from a “c-” rating to a “d+” rating in a research note on Thursday, April 25th. Zacks Investment Research upgraded shares of Natus Medical from a “strong sell” rating to a “hold” rating in a research note on Tuesday, April 16th. Finally, ValuEngine upgraded shares of Natus Medical from a “sell” rating to a “hold” rating in a research note on Monday, April 1st. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and two have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $36.00.

Institutional investors have recently made changes to their positions in the stock. Pearl River Capital LLC acquired a new stake in shares of Natus Medical during the 4th quarter worth about $30,000. Northwestern Mutual Wealth Management Co. acquired a new stake in shares of Natus Medical during the 1st quarter worth about $25,000. Royce & Associates LP increased its position in shares of Natus Medical by 55.4% during the 1st quarter. Royce & Associates LP now owns 1,100 shares of the medical equipment provider’s stock worth $28,000 after purchasing an additional 392 shares in the last quarter. Meeder Asset Management Inc. acquired a new stake in shares of Natus Medical during the 1st quarter worth about $38,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Natus Medical by 51.2% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,495 shares of the medical equipment provider’s stock worth $85,000 after purchasing an additional 845 shares in the last quarter. Institutional investors and hedge funds own 86.89% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was first posted by Baseball Daily News and is owned by of Baseball Daily News. If you are accessing this news story on another website, it was stolen and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this news story can be read at https://www.baseballdailydigest.com/news/2019/05/23/dong-chune-christopher-chung-sells-3500-shares-of-natus-medical-inc-baby-stock.html.

About Natus Medical

Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders.

Further Reading: What is the yield curve?

Insider Buying and Selling by Quarter for Natus Medical (NASDAQ:BABY)

Receive News & Ratings for Natus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical and related companies with MarketBeat.com's FREE daily email newsletter.